Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.71 |
| ▸ | HTT | P42858 | 1/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15983422 | 0.85 | ALDH1A1 (0.80) | ALDH1A1L3MBTL1KDM4ELMNATSHR | |
| SCHEMBL15983644 | 0.81 | ALDH1A1 (0.77) | ALDH1A1L3MBTL1KDM4ELMNATSHR | |
| SCHEMBL6410613 | 0.81 | KMT2A (0.76) | ALDH1A1HTTLMNATSHRMAPK1 | |
| SCHEMBL6407431 | 0.81 | ALDH1A1 (0.69) | ALDH1A1HTTL3MBTL1KDM4ELMNA | |
| SCHEMBL6402415 | 0.80 | ALDH1A1 (0.74) | ALDH1A1L3MBTL1KDM4ELMNATSHR | |
| SCHEMBL15983638 | 0.80 | ALDH1A1 (0.74) | ALDH1A1L3MBTL1KDM4ELMNATSHR | |
| SCHEMBL6061302 | 0.80 | ALDH1A1 (0.74) | ALDH1A1HTTL3MBTL1KDM4ELMNA | |
| SCHEMBL18556536 | 0.79 | LMNA (0.68) | ALDH1A1L3MBTL1LMNATSHRMAPK1 | |
| SCHEMBL4206347 | 0.76 | ALDH1A1 (0.78) | ALDH1A1HTTL3MBTL1LMNATSHR | |
| SCHEMBL15986576 | 0.76 | ALDH1A1 (1.00) | ALDH1A1L3MBTL1KDM4ETSHRATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | AGRIUS GROUP, LLC. | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | ABCG2, ATP5ME, DNTT | ALDH1A1 720/4885HTT 2113/4885L3MBTL1 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.